A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine
J Eur Acad Dermatol Venereol
.
2022 Jan;36(1):e13-e16.
doi: 10.1111/jdv.17676.
Epub 2021 Oct 5.
Authors
J Young
1
,
L Mercieca
1
,
M Ceci
2
,
D Pisani
2
,
A Betts
2
,
M J Boffa
1
Affiliations
1
Department of Dermatology, Mater Dei Hospital, Msida, Malta.
2
Department of Pathology, Mater Dei Hospital, Msida, Malta.
PMID:
34547137
PMCID:
PMC8661451
DOI:
10.1111/jdv.17676
No abstract available
Publication types
Case Reports
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Pemphigoid, Bullous*
SARS-CoV-2
Vaccines, Synthetic
mRNA Vaccines
Substances
COVID-19 Vaccines
Vaccines, Synthetic